Bausch Health Cos Net Cash Flow 2010-2024 | BHC

Bausch Health Cos net cash flow from 2010 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
Bausch Health Cos Annual Net Cash Flow
(Millions of US $)
2024 $239
2023 $371
2022 $-1,528
2021 $303
2020 $-1,428
2019 $2,521
2018 $-74
2017 $255
2016 $-55
2015 $274
2014 $-277
2013 $-316
2012 $752
2011 $-230
2010 $280
2009 $-203
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.876B $9.625B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.477B 5.66
Dr Reddy's Laboratories (RDY) India $11.411B 21.77
BridgeBio Pharma (BBIO) United States $6.430B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.717B 16.02
Amphastar Pharmaceuticals (AMPH) United States $1.109B 6.71
Personalis (PSNL) United States $0.282B 0.00
Taysha Gene Therapies (TSHA) United States $0.254B 0.00
Assembly Biosciences (ASMB) United States $0.075B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.003B 0.00
Teligent (TLGT) United States $0.000B 0.00